<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001055947</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001815442</issuerCik>
      <issuerName>Kymera Therapeutics, Inc.</issuerName>
      <secFileNumber>001-39460</secFileNumber>
      <issuerAddress>
        <com:street1>500 NORTH BEACON STREET, 4TH FLOOR</com:street1>
        <com:city>WATERTOWN</com:city>
        <com:stateOrCountry>MA</com:stateOrCountry>
        <com:zipCode>02472</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>857-285-5314</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>BVF PARTNERS L P/IL</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Affiliate of Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Jefferies LLC</name>
        <address>
          <com:street1>520 Madison Ave</com:street1>
          <com:street2>4th Fl</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>1630658</noOfUnitsSold>
      <aggregateMarketValue>189906430.68</aggregateMarketValue>
      <noOfUnitsOutstanding>82257588</noOfUnitsOutstanding>
      <approxSaleDate>06/26/2026</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>08/21/2020</acquiredDate>
      <natureOfAcquisitionTransaction>Acquired upon the automatic conversion of private shares in connection with the Issuer's initial public offering on August 21, 2020. The private shares were acquired and fully paid for on March 11, 2020.</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>1630658</amountOfSecuritiesAcquired>
      <paymentDate>08/21/2020</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>BVF Partners, L.P. (BVF) is the investment manager of certain funds and/or managed accounts that are selling the shares. BVF is also an affiliate of a director of the Issuer. The aggregate market value is as of the close of business on June 25, 2026. The number of securities outstanding is as of April 24, 2026.</remarks>
    <noticeSignature>
      <noticeDate>06/26/2026</noticeDate>
      <signature>Mark N. Lampert, President of BVF Inc., the general partner of BVF</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
